Acute Cerebellar Ataxia and Myoclonus in SARS-CoV-2-Related Encephalopathy Responsive to Immunotherapy: A Case Series

Mov Disord Clin Pract. 2023 Feb;10(2):343-345. doi: 10.1002/mdc3.13598. Epub 2022 Oct 29.

Authors

Matteo Grazzini¹, Massimiliano Godani¹, Stefano Grisanti², Luana Benedetti³, Giuseppe Lanza^{4

5}

Affiliations

¹ Neurology Unit, Sant'Andrea Civic Hospital, La Spezia, Italy.
² Neurology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
³ IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
⁴ Department of Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy.
⁵ Clinical Neurophysiology Research Unit, Oasi Research Institute-IRCCS, Troina, Italy.

No abstract available

Keywords: SARS-CoV-2; ataxia; immunotherapy; myoclonus; neurological complications.

Publication types

Letter

MeSH terms

Acute Disease
Brain Diseases*
COVID-19*
Cerebellar Ataxia* / therapy
Humans
Immunotherapy / adverse effects
Myoclonus* / etiology
SARS-CoV-2